Aurinia Pharmaceuticals AUPH Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Aurinia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aurinia Pharmaceuticals's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aurinia Pharmaceuticals's net income?
- Aurinia Pharmaceuticals (AUPH) reported net income of $34.36M in Q1 2026.
- How has Aurinia Pharmaceuticals's net income changed year-over-year?
- Aurinia Pharmaceuticals's net income increased by 47.2% year-over-year, from $23.34M to $34.36M.
- What is the long-term trend for Aurinia Pharmaceuticals's net income?
- Over 4 years (2021 to 2025), Aurinia Pharmaceuticals's net income has grown at a 12.2% compound annual growth rate (CAGR), from -$180.97M to $287.2M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.